ANEB OTC
Anebulo Pharmaceuticals, Inc.
1W: -1.5%
1M: +6.7%
3M: -13.0%
YTD: -71.7%
1Y: -86.7%
3Y: -90.2%
5Y: -95.4%
$0.32
+0.00 (+0.00%)
Weekly Expected Move ±12.6%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
2 relationships2
As Filer
counterparties named
0
As Counterparty
mentioned by others
2
Rel. Types
2023-03-08
Earliest Filing
2023-03-08
Latest Filing
customer: 1
supplier: 1
Counterparties (Filed by ANEB)
2 relationshipsCompanies named in ANEB's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Anebulo Pharmaceuticals, Inc. | ANEB | customer | Company engaging Potrero for strategic and financial advice services | 2023-03-08 | View |
| Potrero Hill Advisors, LLC. | — | supplier | Independent consultant providing strategic and financial advice services | 2023-03-08 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-02-12 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2026-02-06 | Notice of Delisting or Transfer; Other Events; Financial Statements and Exhibits | View | |
| 2026-01-29 | Other Events; Financial Statements and Exhibits | View | |
| 2026-01-27 | Other Events; Financial Statements and Exhibits | View | |
| 2025-12-22 | Other Events; Financial Statements and Exhibits | View | |
| 2025-11-13 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-09-29 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-09-12 | Other Events; Financial Statements and Exhibits | View | |
| 2025-07-23 | Other Events; Financial Statements and Exhibits | View | |
| 2025-05-13 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-04-15 | Other Events | View | |
| 2025-04-14 | Amendments to Articles of Incorporation or Bylaws; Financial Statements and Exhibits | View | |
| 2025-04-07 | Departure/Election of Directors; Appointment of Officers; Submission of Matters to a Vote of Securit | View | |
| 2025-02-24 | Entry into Material Definitive Agreement; Notice of Delisting or Transfer; Financial Statements and | Agreement | View |
| 2025-02-14 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-02-12 | Other Events | View | |
| 2024-12-23 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Changes in Contro | Agreement | View |
| 2024-11-13 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2024-10-17 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2024-09-25 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR